1 citations
,
July 2017 in “Journal of evolution of medical and dental sciences” In this study, common skin conditions in the geriatric population of Kerala were found to be widely prevalent, with significant associations between xanthelasma palpebrarum and dyslipidemia, and between cherry angioma and diabetes.
January 2026 in “Animal Advances” In this study of four Chinese goat breeds, black goats exhibited significantly higher melanin content, while Inner Mongolian cashmere goats had longer fiber lengths. These findings highlight genetic variations in coat color and fiber length, informing future breeding programs.
January 2026 in “Annals of Dermatology” This study found high levels of anxiety, depression, and PTSD in dermatology patients one year after the February 6, 2023, earthquakes in Türkiye, with specific skin conditions like telogen effluvium and alopecia areata being more prevalent among those with psychological distress.
January 2025 in “The World Journal of Men s Health” In this study, autologous intratesticular PRP injection was found to be a feasible and well-tolerated procedure with low complication rates and quick recovery, but the authors indicated that current evidence is insufficient to confirm its effectiveness for mTESE.
9 citations
,
August 2024 in “British Journal of Dermatology” This study highlights that the incidence and mental health impact of alopecia areata is higher among non-White ethnic groups, emphasizing the need for targeted healthcare for those at greatest risk.
1 citations
,
September 2023 in “eLife” This study found that TLR2 expression in hair follicle stem cells is crucial for hair follicle maintenance and regeneration, with TLR2-dependent activation potentially offering new therapeutic approaches for hair loss prevention through mechanisms involving immune pathways and CEP administration.
June 2023 in “Journal of Cosmetic Dermatology” This research highlights that while minoxidil and 5-alpha reductase inhibitors are commonly used for treating pattern hair loss, there is limited evidence supporting their relative effectiveness in women compared to men.
This study found that in live mouse epidermal stem cells, chromatin compaction is heterogenous and reflects differentiation status, with transcriptional changes largely preceding chromatin rearrangements during differentiation.
1 citations
,
January 2025 in “CPT Pharmacometrics & Systems Pharmacology” In this study, the researchers evaluated the exposure-response relationship of ritlecitinib on eyebrow and eyelash regrowth and concluded that the established models justify selecting a 50 mg dose for patients with severe alopecia areata, while highlighting differing efficacy among evaluation methods.
23 citations
,
September 2020 in “BMC Cancer” This retrospective cohort study found that patients using 5α-reductase inhibitors had reduced bladder cancer-related mortality compared to nonusers, with no significant effect on bladder cancer recurrence or upper tract urothelial carcinoma mortality.
This study utilized the USFDA AERS to identify significant associations between various medications—such as anti-osteoporotic drugs and phenytoin—and gingival disorders, noting emergent signals with finasteride, COVID-19 vaccine, and levothyroxine, suggesting a need for awareness of oral side effects.
July 2024 in “Journal of Investigative Dermatology” Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.
April 2026 in “World Allergy Organization Journal” This study found that allergic rhinitis is linked to a higher risk of developing androgenetic alopecia, while second-generation H1-antihistamine use was associated with a reduced risk, especially in younger patients.
1 citations
,
July 2022 in “International Journal of Environmental Research and Public Health” This study observed seasonal trends in Poland's Google searches for dermatology-related terms and noted a decrease in searches for sexually transmitted diseases despite rising infection rates, highlighting a need for better sexual education.
July 2026 in “Journal of the American Academy of Dermatology” JAK inhibitors help regrow eyebrow and eyelash hair and improve anxiety and depression in some alopecia areata patients.
November 2024 in “Skin Appendage Disorders” In this study, researchers assessed the quality of life in patients with different types of alopecia using the Skindex-29 and DLQI questionnaires, finding that telogen effluvium and alopecia areata had the greatest pretreatment impact on quality of life, with moderate responsiveness observed after treatment.
July 2013 in “Neurosurgery” This review discusses the use of spinal fMRI to investigate the brainstem and spinal cord and highlights its potential for understanding functional integration, but it reports no new experimental results.
4 citations
,
October 2025 in “Science Advances” In this study, researchers found that tubular VCAM1 expression in transgenic mice and human kidney transplant biopsies precedes nephron loss and fibrosis, indicating its potential as an early biomarker for tubular fate and adverse kidney outcomes.
34 citations
,
June 2015 in “Journal of cardiovascular pharmacology and therapeutics” This article discusses the use of direct vasodilators and sympatholytic agents in hypertension management, highlighting their utility in specific cases like refractory hypertension and heart failure, but reports no new clinical results.
24 citations
,
December 2016 in “Psychiatric Clinics of North America” This review discusses hormonal and surgical gender-affirming interventions for transfeminine individuals, noting improvements in quality of life and mental health with minimal adverse effects, but reports no new research findings.
18 citations
,
June 2017 in “Journal of the neurological sciences” In this study, the use of 5 alpha reductase inhibitors was associated with an increased risk of dementia during the first two years of treatment, but the risk was not significant with longer exposure.
15 citations
,
September 2021 in “Frontiers in Endocrinology” This review discusses the impact of gender affirming hormone therapy on cardiovascular outcomes in transgender individuals and reports no new clinical results; the authors underscore the need for more comprehensive studies.
7 citations
,
September 2023 in “JAMA Dermatology” This study reviewed treatment patterns for adults with alopecia areata in the US from 2015 to 2020, revealing that corticosteroids were the most common treatment, yet over two-thirds of patients were not receiving any treatment a year after diagnosis.
August 2026 in “Lasers in Medical Science” This review suggests that hyperspectral and terahertz imaging show promise in non-invasively assessing scalp changes associated with hair loss, but further validation is needed for clinical application.
June 2026 in “IP Indian Journal of Clinical and Experimental Dermatology” This study found that trichoscopic parameters in male androgenetic alopecia deteriorated progressively with increasing disease severity and were significantly linked to genetic, metabolic, and psychosocial factors.
May 2026 in “Journal of Clinical Medicine” This meta-analysis found a significantly higher prevalence of depressive symptoms in women with PCOS compared to a control group, with 42.11% versus 13.62% according to the BDI assessment, highlighting the need for psychiatric evaluation and support for women with this syndrome.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” This policy brief found that post-drug syndromes are under-recognized in current pharmacovigilance systems, leading to inadequate risk assessments and prolonged patient harm from persistent drug-induced conditions.
January 2025 in “Animal Science Journal” This study reported that the coat hairs of golden takin, living in harsh environments, have unique structural features compared to cattle, with overcoat hairs having continuous medullated tissue and undercoat hairs being finely crimped, potentially contributing to temperature regulation in cold conditions.
January 2025 in “Therapeutic Advances in Medical Oncology” This study found that many young women with breast cancer experience a poor quality of life over time, especially regarding sexual health, future perspective, and hair loss.
April 2023 in “Cancer Research” This study demonstrated that human plucked hairs can be used as a valuable biomarker to evaluate the pharmacodynamic responses of various chemotherapy agents ex vivo, supporting their potential use for assessing oncology drug target engagement prior to clinical studies.